Literature DB >> 25611120

Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies.

Xiufeng Wu1, Arlene J Sereno, Flora Huang, Kai Zhang, Micheal Batt, Jonathan R Fitchett, Dongmei He, Heather L Rick, Elaine M Conner, Stephen J Demarest.   

Abstract

Immunoglobulins and T cell receptors (TCRs) share common sequences and structures. With the goal of creating novel bispecific antibodies (BsAbs), we generated chimeric molecules, denoted IgG_TCRs, where the Fv regions of several antibodies were fused to the constant domains of the α/β TCR. Replacing CH1 with Cα and CL with Cβ, respectively, was essential for achieving at least partial heavy chain/light chain assembly. Further optimization of the linker regions between the variable and constant domains, as well as replacement of the large FG loop of Cβ with a canonical β-turn, was necessary to consistently obtain full heavy chain/light chain assembly. The optimized IgG_TCR molecules were evaluated biophysically and shown to maintain the binding properties of their parental antibodies. A few BsAbs were generated by co-expressing native Fabs and IgG_TCR Fabs within the same molecular construct. We demonstrate that the IgG_TCR designs steered each of the light chains within the constructs to specifically pair with their cognate heavy chain counterparts. We did find that even with complete constant domain specificity between the CH1/CL and Cα/Cβ domains of the Fabs, strong variable domain interactions can dominate the pairing specificity and induce some mispairing. Overall, the IgG_TCR designs described here are a first step toward the generation of novel BsAbs that may be directed toward the treatment of multi-faceted and complex diseases.

Entities:  

Keywords:  DSC, differential scanning calorimetry; FG loop; HC, heavy chain; Ha, heavy chain containing Ca in place of CH1; Hb, heavy chain containing Cb in place of CH1; LC, light chain; La, heavy chain containing Ca in place of CL; Lb, heavy chain containing Cb in place of CL; RU, resonance units; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; SEC, size exclusion chromatography; SPR, surface plasmon resonance; T cell receptor; TCR, T cell receptor; bispecific antibody; protein chimera; protein design

Mesh:

Substances:

Year:  2015        PMID: 25611120      PMCID: PMC4623437          DOI: 10.1080/19420862.2015.1007826

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  40 in total

1.  Redirecting the complete T cell receptor/CD3 signaling machinery towards native antigen via modified T cell receptor.

Authors:  T Brocker; M Riedinger; K Karjalainen
Journal:  Eur J Immunol       Date:  1996-08       Impact factor: 5.532

2.  Design and production of novel tetravalent bispecific antibodies.

Authors:  M J Coloma; S L Morrison
Journal:  Nat Biotechnol       Date:  1997-02       Impact factor: 54.908

3.  A novel approach for preparing anti-T cell receptor constant region antibodies.

Authors:  A Traunecker; B Dolder; K Karjalainen
Journal:  Eur J Immunol       Date:  1986-07       Impact factor: 5.532

4.  Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab.

Authors:  Hyun-Soo Cho; Karen Mason; Kasra X Ramyar; Ann Marie Stanley; Sandra B Gabelli; Dan W Denney; Daniel J Leahy
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

5.  Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

Authors:  G Gross; T Waks; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  New simplified molecular design for functional T cell receptor.

Authors:  T Brocker; A Peter; A Traunecker; K Karjalainen
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

7.  The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells.

Authors:  Rita Nahta; Mien-Chie Hung; Francisco J Esteva
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

8.  Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.

Authors:  Matthew C Franklin; Kendall D Carey; Felix F Vajdos; Daniel J Leahy; Abraham M de Vos; Mark X Sliwkowski
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

9.  T cell receptor-extracellular constant regions as hetero-cross-linkers for immunoglobulin variable regions.

Authors:  H Seimiya; M Naito; T Mashima; H Yasui; Y Kuwana; Y Kurosawa; T Tsuruo
Journal:  J Biochem       Date:  1993-06       Impact factor: 3.387

10.  Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions.

Authors:  Y Kuwana; Y Asakura; N Utsunomiya; M Nakanishi; Y Arata; S Itoh; F Nagase; Y Kurosawa
Journal:  Biochem Biophys Res Commun       Date:  1987-12-31       Impact factor: 3.575

View more
  7 in total

1.  Fab-based bispecific antibody formats with robust biophysical properties and biological activity.

Authors:  Xiufeng Wu; Arlene J Sereno; Flora Huang; Steven M Lewis; Ricky L Lieu; Caroline Weldon; Carina Torres; Cody Fine; Micheal A Batt; Jonathan R Fitchett; Andrew L Glasebrook; Brian Kuhlman; Stephen J Demarest
Journal:  MAbs       Date:  2015       Impact factor: 5.857

2.  CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications.

Authors:  Anke Steinmetz; François Vallée; Christian Beil; Christian Lange; Nicolas Baurin; Jochen Beninga; Cécile Capdevila; Carsten Corvey; Alain Dupuy; Paul Ferrari; Alexey Rak; Peter Wonerow; Jochen Kruip; Vincent Mikol; Ercole Rao
Journal:  MAbs       Date:  2016-03-16       Impact factor: 5.857

Review 3.  The making of bispecific antibodies.

Authors:  Ulrich Brinkmann; Roland E Kontermann
Journal:  MAbs       Date:  2017 Feb/Mar       Impact factor: 5.857

4.  A new approach to produce IgG4-like bispecific antibodies.

Authors:  Caizhi Zhao; Wei Zhang; Guihua Gong; Liping Xie; Ming-Wei Wang; Youjia Hu
Journal:  Sci Rep       Date:  2021-09-20       Impact factor: 4.379

5.  The eIg technology to generate Ig-like bispecific antibodies.

Authors:  Lennart Kühl; Nadine Aschmoneit; Roland E Kontermann; Oliver Seifert
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

6.  Comparing domain interactions within antibody Fabs with kappa and lambda light chains.

Authors:  Raheleh Toughiri; Xiufeng Wu; Diana Ruiz; Flora Huang; John W Crissman; Mark Dickey; Karen Froning; Elaine M Conner; Thomas P Cujec; Stephen J Demarest
Journal:  MAbs       Date:  2016-07-25       Impact factor: 5.857

7.  Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics.

Authors:  Karen Froning; Jack Maguire; Arlene Sereno; Flora Huang; Shawn Chang; Kenneth Weichert; Anton J Frommelt; Jessica Dong; Xiufeng Wu; Heather Austin; Elaine M Conner; Jonathan R Fitchett; Aik Roy Heng; Deepa Balasubramaniam; Mark T Hilgers; Brian Kuhlman; Stephen J Demarest
Journal:  Nat Commun       Date:  2020-05-11       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.